Topic Menu
► Topic MenuTopic Editors


2. Center for Microscopy and Molecular Imaging, Rue Adrienne Bolland, 8, B-6041 Gosselies, Belgium
Pharmaceutical Application of Magnetic Iron Oxide Nanoparticles
Topic Information
Dear Colleagues,
In the field of nanotechnology, recent decades have witnessed the emergence of many nanosystems exhibiting customized properties, which are of major interest for many applications. Among the existing nanomaterials, superparamagnetic iron oxide nanoparticles (SPIO) have emerged as promising thanks to their remarkable magnetic properties, especially for biomedical applications, where their efficiency as a contrast enhancer for magnetic resonance imaging (MRI) has been widely documented. The development of emerging technologies, such as magnetic hyperthermia, cell tracking, drug delivery, molecular imaging, or, more recently, magnetic particle imaging (MPI), has encouraged the continued development of reliable procedures to produce nanoparticles exhibiting desirable properties. This Topic explores the potential of magnetic nanoconstructs in biomedicine. Potential topics include, but are not limited to:
- SPIO development, synthesis, and characterization for biomedical applications;
- Surface modification/functionalization for biomedical applications, including molecular and multimodal imaging;
- Scale-up, reproducibility, and qualification of nanoparticle batches produced for biomedical applications;
- Original approaches for the synthesis of magnetic nanoparticles intended for biomedical applications;
- Evaluation of particles’ toxicity/innocuity, including the development of original models;
- The use of SPIO for innovative imaging modalities (e.g. magnetic particle imaging, MSOT, etc.);
- The evaluation of their potential as therapeutic agents alone, or in combination (e.g., radiosensitizing properties, drug delivery, etc.).
Dr. Dimitri Stanicki
Prof. Dr. Sophie Laurent
Topic Editors
Keywords
- contrast agents
- molecular imaging
- multimodal imaging
- drug delivery
- SPIO synthesis
- theranostic
Participating Journals
Journal Name | Impact Factor | CiteScore | Launched Year | First Decision (median) | APC |
---|---|---|---|---|---|
![]()
Applied Sciences
|
2.5 | 5.3 | 2011 | 18.4 Days | CHF 2400 |
![]()
Pharmaceutics
|
4.9 | 7.9 | 2009 | 15.5 Days | CHF 2900 |
![]()
Magnetochemistry
|
2.6 | 3.9 | 2015 | 15.8 Days | CHF 2200 |
![]()
Journal of Functional Biomaterials
|
5.0 | 4.6 | 2010 | 16.6 Days | CHF 2700 |
![]()
Nanomaterials
|
4.4 | 8.5 | 2010 | 14.1 Days | CHF 2400 |
Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.
MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:
- Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
- Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
- Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
- Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
- Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.